World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
24663
World Ranking
14231
National Ranking
7197

David S. Goldfarb publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where David S. Goldfarb sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 389 publications — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

David S. Goldfarb D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where David S. Goldfarb sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

David S. Goldfarb is affiliated with the University of Rochester in the United States. Their research primarily focuses on medicine, with significant work in pulmonary and respiratory medicine, nephrology, pediatrics, perinatology, child health, pathology and forensic medicine, and molecular biology.

The scientist's work often addresses topics related to kidney stones and urolithiasis treatments, pediatric urology and nephrology studies, dialysis and renal disease management, biomedical research and pathophysiology, porphyrin metabolism and disorders, climate change and health impacts, and poisoning and overdose treatments.

Notable recent publications include:

  • Epidemiology of Kidney Stones, 2023, Healthcare
  • Impending Shortages of Kidney Replacement Therapy for COVID-19 Patients, 2020, Clinical Journal of the American Society of Nephrology
  • Urine and stone analysis for the investigation of the renal stone former: a consensus conference, 2020, Urolithiasis
  • Cystinuria: an update on pathophysiology, genetics, and clinical management, 2021, Pediatric Nephrology
  • Evaluation and Medical Management of Patients with Cystine Nephrolithiasis: A Consensus Statement, 2020, Journal of Endourology

Frequent coauthors collaborating with Goldfarb include:

  • Frank Modersitzki
  • John R. Asplin
  • Thomas D. Nolin
  • John C. Lieske
  • Lama Nazzal

Goldfarb's publications are often found in journals such as:

  • Current Opinion in Nephrology & Hypertension
  • Urolithiasis
  • Journal of the American Society of Nephrology
  • Urology
  • Clinical Journal of the American Society of Nephrology

The research spans across multiple specialized subfields, which include:

  • Pulmonary and Respiratory Medicine
  • Nephrology
  • Pediatrics, Perinatology and Child Health
  • Pathology and Forensic Medicine
  • Molecular Biology

David S. Goldfarb has contributed extensively to medical science with a focus on kidney-related disorders and the management of renal disease, demonstrating expertise in interdisciplinary areas that intersect nephrology, pediatrics, and respiratory medicine.

Best Publications

  • A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells

    Michael I. Bukrinsky;Sheryl Haggerty;Michael P. Dempsey;Natalia Sharova

  • Method for altering the lifespan of eukaryotic organisms

    David Scott Goldfarb

  • Medical management of kidney stones: AUA guideline.

    Margaret S. Pearle;David S. Goldfarb;Dean G. Assimos;Gary Curhan

  • Importin α: A multipurpose nuclear-transport receptor

    David S. Goldfarb;Anita H. Corbett;D. Adam Mason;Michelle T. Harreman

  • Synthetic peptides as nuclear localization signals.

    David S. Goldfarb;Jean Gariépy;Gary Schoolnik;Roger D. Kornberg

  • Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.

    Rex L. Jamison;Pamela Hartigan;James S. Kaufman;David S. Goldfarb

  • Piecemeal Microautophagy of Nucleus in Saccharomyces cerevisiae

    Paul Roberts;Sharon Moshitch-Moshkovitz;Erik Kvam;Eileen O'Toole

  • Minimal nuclear pore complexes define FG repeat domains essential for transport

    Lisa A. Strawn;Tianxiang Shen;Tianxiang Shen;Nataliya Shulga;David S. Goldfarb

  • Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment

    Yael R. Nobel;Laura M. Cox;Francis F. Kirigin;Nicholas A. Bokulich

  • Nucleus-vacuole junctions in Saccharomyces cerevisiae are formed through the direct interaction of Vac8p with Nvj1p.

    Xiaozhou Pan;Paul Roberts;Yan Chen;Erik Kvam

  • Facilitated nuclear transport of histone H1 and other small nucleophilic proteins.

    Mirjam Breeuwer;David S. Goldfarb

  • Subcutaneous Compared with Intravenous Epoetin in Patients Receiving Hemodialysis

    James S. Kaufman;Domenic J. Reda;Carol L. Fye;David S. Goldfarb

  • A twin study of genetic and dietary influences on nephrolithiasis: A report from the Vietnam Era Twin (VET) Registry

    David S. Goldfarb;Mary E. Fischer;Yona Keich;Jack Goldberg

  • Randomized Controlled Trial of Clopidogrel plus Aspirin to Prevent Hemodialysis Access Graft Thrombosis

    James S Kaufman;Theresa Z O'Connor;Jane Hongyuan Zhang;Robert E Cronin

  • KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD

    Alan S. Kliger;Robert N. Foley;David S. Goldfarb;Stuart L. Goldstein

  • Protein import through the nuclear pore complex is a multistep process.

    C W Akey;D S Goldfarb

  • Hereditary Causes of Kidney Stones and Chronic Kidney Disease

    Vidar O. Edvardsson;Vidar O. Edvardsson;Vidar O. Edvardsson;David S. Goldfarb;David S. Goldfarb;John C. Lieske;Lada Beara-Lasic;Lada Beara-Lasic

  • In vivo nuclear transport kinetics in Saccharomyces cerevisiae: a role for heat shock protein 70 during targeting and translocation.

    N Shulga;P Roberts;Z Gu;L Spitz

  • Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease

    Natarajan Ranganathan;Pari Ranganathan;Eli A. Friedman;Anthony Joseph

  • The association of nephrolithiasis with cystic fibrosis.

    Eric M. Gibney;David S. Goldfarb

Frequent Co-Authors

Robert S. Hoffman
Robert S. Hoffman New York University
John C. Lieske
John C. Lieske Mayo Clinic
Huilin Li
Huilin Li Van Andel Institute
Fredric L. Coe
Fredric L. Coe University of Chicago
Paul I. Dargan
Paul I. Dargan Guy's and St Thomas' NHS Foundation Trust
J. Michael Gaziano
J. Michael Gaziano Brigham and Women's Hospital
Gary C. Curhan
Gary C. Curhan Brigham and Women's Hospital
Bruno Mégarbane
Bruno Mégarbane Université Paris Cité
Kamyar Kalantar-Zadeh
Kamyar Kalantar-Zadeh University of California, Irvine
Michael D. Ward
Michael D. Ward New York University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA doesn’t always mean following the traditional path to becoming a physician. There are many related online degrees and career pathways that offer flexibility, financial aid, and opportunities for career advancement.

For those interested in the business side of healthcare, medical billing and coding schools with financial aid allow students to train for in-demand roles quickly and affordably. Aspiring nurses can explore nursing schools that don't require teas or hesi, eliminating traditional exam barriers and making entry into nursing smoother.

Those aiming for leadership roles may want to consider a healthcare administration degree, which can be earned online at an accelerated pace for faster career progression. Additionally, registered nurses with an associate’s degree can jumpstart their careers by enrolling in adn to msn bridge programs, seamlessly advancing their qualifications and expertise.

These pathways provide flexible, accessible options for entering and advancing in the expanding healthcare sector.

Best Scientists Citing David S. Goldfarb

Trending Scientists

Recently Published Articles